{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-040036","form_type":"8-K","ticker":"MMED","cik":"0002062583","company_name":"MiniMed Group, Inc.","filed_at":"2026-06-03T10:50:57+00:00","discovered_at":"2026-06-03T10:55:00.282550+00:00","generated_at":"2026-06-03T10:55:10.608054+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"MiniMed Q4 net sales $837M (+16% as reported); FY27 organic growth guidance ~10%","bullets":["Q4 net sales $837M (+15.6% as reported, +8.7% organic); International $599M (+22.4% as reported, +12.2% organic).","Full FY26 net sales $3.102B (+14.2% as reported, +8.0% organic); first annual revenue >$3B.","Worldwide New Pumps Sold ~42,000 in Q4 (+7.4% QoQ); FY26 total ~145,000 flat YoY; CGM attachment rate 66% (+700 bps YoY).","FY27 guidance: organic revenue growth ~10% (including ~1.0-1.5% extra week benefit); adjusted EBITDA margin ~16%.","Product milestones: MiniMed Flex FDA clearance, MiniMed Go US launch, extension of Abbott partnership for dual glucose-ketone sensors."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-040036","json":"https://secwatch.observer/filing/0001628280-26-040036.json","markdown":"https://secwatch.observer/filing/0001628280-26-040036.md","text":"https://secwatch.observer/filing/0001628280-26-040036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2062583/000162828026040036/0001628280-26-040036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2062583/000162828026040036/mmed-20260603.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T10:55:10.608054+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"df3e7f2d227aaef43318db19fe6ab07c636ee144","claim":"MiniMed Group, Inc. reported financial results for fourth quarter and full fiscal year ended April 24, 2026.","evidence_excerpt":"On June 3, 2026, MiniMed Group, Inc., a Delaware corporation (the \"Company\"), issued a press release announcing its financial results and related information for its fourth quarter and full fiscal year 2026.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2062583/000162828026040036/0001628280-26-040036-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and full fiscal year ended April 24, 2026"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}